Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment

Wen Liao, Hai Wei, Xiaoyan Wang, Yunping Qiu, Xiaojun Gou, Xiaolei Zhang, Mingmei Zhou, Jianbing Wu, Tao Wu, Fang Kou, Yongyu Zhang, Zhaoxiang Bian, Guoxiang Xie, Wei Jia

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Resveratrol (Res), 3,5,4′-trihydroxy-trans-stilbene, is an antioxidant found in the skin of red grapes and in several other plants. This phenolic compound has been recently reported to possess cancer chemopreventive activity that inhibits the process of carcinogenesis. However, the mechanisms underlying its anticancer effects remain largely unresolved. In this study, we investigated the chemoprotective effects of dietary Res in an azoxymethane (AOM) induced precancerous colorectal lesion model in male Wistar rats. The metabolic alterations in urine, sera, and colonic tissues of experimental rats perturbed by AOM intervention as well as the Res treatment were measured by a gas chromatography time-of-flight mass spectrometry (GC-TOFMS) analysis. Significant alterations of metabolites were observed in AOM group in urine, sera, and colonic tissues, which were attenuated by Res treatment and concurrent with the histopathological improvement with significantly decreased aberrant crypt foci (ACF) incidence. Representative metabolites include depleted glucose, β-hydroxybutyrate (ketone body), hypoxanthine, and elevated branched chain amino acids (isoleucine and valine) and tryptophan in colonic tissue, as well as elevated serum aminooxyacetate and urinary 4-hydroxyphenylacetate and xanthurenate. These metabolic changes suggest that the preventive effect of Res is associated with attenuation of impaired glucose and lipid metabolism and elevated protein breakdown in colonic tissues from AOM-exposed rats. It also appears that Res induced significant metabolic alterations independent of the AOM-induced metabolic changes. The significantly altered metabolites identified in Res-AOM group relative to AOM group include arachidonate, linoleate, glutamate, docosahexaenoate, palmitelaidate, 2-aminobutyrate, pyroglutamate, and threonate, all of which are involved in inflammation and oxidation processes. This suggests that Res exerts the chemopreventive effects on ACF formation by anti-inflammatory and antioxidant mechanisms in addition to amelioration of AOM-induced mitochondrial disruption.

Original languageEnglish (US)
Pages (from-to)3436-3448
Number of pages13
JournalJournal of Proteome Research
Volume11
Issue number6
DOIs
StatePublished - Jun 1 2012
Externally publishedYes

Fingerprint

Azoxymethane
Metabolomics
Metabolites
Aberrant Crypt Foci
Tissue
Rats
Antioxidants
Serum
Aminooxyacetic Acid
Pyrrolidonecarboxylic Acid
Urine
Hydroxybutyrates
Aminobutyrates
Glucose
Stilbenes
Ketone Bodies
Branched Chain Amino Acids
Hypoxanthine
resveratrol
Docosahexaenoic Acids

Keywords

  • AOM
  • azoxymethane
  • colorectal cancer
  • gas chromatography time-of-flight mass spectrometry
  • GC-TOFMS
  • metabonomics
  • resveratrol

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)
  • Medicine(all)

Cite this

Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment. / Liao, Wen; Wei, Hai; Wang, Xiaoyan; Qiu, Yunping; Gou, Xiaojun; Zhang, Xiaolei; Zhou, Mingmei; Wu, Jianbing; Wu, Tao; Kou, Fang; Zhang, Yongyu; Bian, Zhaoxiang; Xie, Guoxiang; Jia, Wei.

In: Journal of Proteome Research, Vol. 11, No. 6, 01.06.2012, p. 3436-3448.

Research output: Contribution to journalArticle

Liao, W, Wei, H, Wang, X, Qiu, Y, Gou, X, Zhang, X, Zhou, M, Wu, J, Wu, T, Kou, F, Zhang, Y, Bian, Z, Xie, G & Jia, W 2012, 'Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment', Journal of Proteome Research, vol. 11, no. 6, pp. 3436-3448. https://doi.org/10.1021/pr300284h
Liao, Wen ; Wei, Hai ; Wang, Xiaoyan ; Qiu, Yunping ; Gou, Xiaojun ; Zhang, Xiaolei ; Zhou, Mingmei ; Wu, Jianbing ; Wu, Tao ; Kou, Fang ; Zhang, Yongyu ; Bian, Zhaoxiang ; Xie, Guoxiang ; Jia, Wei. / Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment. In: Journal of Proteome Research. 2012 ; Vol. 11, No. 6. pp. 3436-3448.
@article{308714d4f9514bbb8348c7abb743e362,
title = "Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment",
abstract = "Resveratrol (Res), 3,5,4′-trihydroxy-trans-stilbene, is an antioxidant found in the skin of red grapes and in several other plants. This phenolic compound has been recently reported to possess cancer chemopreventive activity that inhibits the process of carcinogenesis. However, the mechanisms underlying its anticancer effects remain largely unresolved. In this study, we investigated the chemoprotective effects of dietary Res in an azoxymethane (AOM) induced precancerous colorectal lesion model in male Wistar rats. The metabolic alterations in urine, sera, and colonic tissues of experimental rats perturbed by AOM intervention as well as the Res treatment were measured by a gas chromatography time-of-flight mass spectrometry (GC-TOFMS) analysis. Significant alterations of metabolites were observed in AOM group in urine, sera, and colonic tissues, which were attenuated by Res treatment and concurrent with the histopathological improvement with significantly decreased aberrant crypt foci (ACF) incidence. Representative metabolites include depleted glucose, β-hydroxybutyrate (ketone body), hypoxanthine, and elevated branched chain amino acids (isoleucine and valine) and tryptophan in colonic tissue, as well as elevated serum aminooxyacetate and urinary 4-hydroxyphenylacetate and xanthurenate. These metabolic changes suggest that the preventive effect of Res is associated with attenuation of impaired glucose and lipid metabolism and elevated protein breakdown in colonic tissues from AOM-exposed rats. It also appears that Res induced significant metabolic alterations independent of the AOM-induced metabolic changes. The significantly altered metabolites identified in Res-AOM group relative to AOM group include arachidonate, linoleate, glutamate, docosahexaenoate, palmitelaidate, 2-aminobutyrate, pyroglutamate, and threonate, all of which are involved in inflammation and oxidation processes. This suggests that Res exerts the chemopreventive effects on ACF formation by anti-inflammatory and antioxidant mechanisms in addition to amelioration of AOM-induced mitochondrial disruption.",
keywords = "AOM, azoxymethane, colorectal cancer, gas chromatography time-of-flight mass spectrometry, GC-TOFMS, metabonomics, resveratrol",
author = "Wen Liao and Hai Wei and Xiaoyan Wang and Yunping Qiu and Xiaojun Gou and Xiaolei Zhang and Mingmei Zhou and Jianbing Wu and Tao Wu and Fang Kou and Yongyu Zhang and Zhaoxiang Bian and Guoxiang Xie and Wei Jia",
year = "2012",
month = "6",
day = "1",
doi = "10.1021/pr300284h",
language = "English (US)",
volume = "11",
pages = "3436--3448",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Metabonomic variations associated with AOM-induced precancerous colorectal lesions and resveratrol treatment

AU - Liao, Wen

AU - Wei, Hai

AU - Wang, Xiaoyan

AU - Qiu, Yunping

AU - Gou, Xiaojun

AU - Zhang, Xiaolei

AU - Zhou, Mingmei

AU - Wu, Jianbing

AU - Wu, Tao

AU - Kou, Fang

AU - Zhang, Yongyu

AU - Bian, Zhaoxiang

AU - Xie, Guoxiang

AU - Jia, Wei

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Resveratrol (Res), 3,5,4′-trihydroxy-trans-stilbene, is an antioxidant found in the skin of red grapes and in several other plants. This phenolic compound has been recently reported to possess cancer chemopreventive activity that inhibits the process of carcinogenesis. However, the mechanisms underlying its anticancer effects remain largely unresolved. In this study, we investigated the chemoprotective effects of dietary Res in an azoxymethane (AOM) induced precancerous colorectal lesion model in male Wistar rats. The metabolic alterations in urine, sera, and colonic tissues of experimental rats perturbed by AOM intervention as well as the Res treatment were measured by a gas chromatography time-of-flight mass spectrometry (GC-TOFMS) analysis. Significant alterations of metabolites were observed in AOM group in urine, sera, and colonic tissues, which were attenuated by Res treatment and concurrent with the histopathological improvement with significantly decreased aberrant crypt foci (ACF) incidence. Representative metabolites include depleted glucose, β-hydroxybutyrate (ketone body), hypoxanthine, and elevated branched chain amino acids (isoleucine and valine) and tryptophan in colonic tissue, as well as elevated serum aminooxyacetate and urinary 4-hydroxyphenylacetate and xanthurenate. These metabolic changes suggest that the preventive effect of Res is associated with attenuation of impaired glucose and lipid metabolism and elevated protein breakdown in colonic tissues from AOM-exposed rats. It also appears that Res induced significant metabolic alterations independent of the AOM-induced metabolic changes. The significantly altered metabolites identified in Res-AOM group relative to AOM group include arachidonate, linoleate, glutamate, docosahexaenoate, palmitelaidate, 2-aminobutyrate, pyroglutamate, and threonate, all of which are involved in inflammation and oxidation processes. This suggests that Res exerts the chemopreventive effects on ACF formation by anti-inflammatory and antioxidant mechanisms in addition to amelioration of AOM-induced mitochondrial disruption.

AB - Resveratrol (Res), 3,5,4′-trihydroxy-trans-stilbene, is an antioxidant found in the skin of red grapes and in several other plants. This phenolic compound has been recently reported to possess cancer chemopreventive activity that inhibits the process of carcinogenesis. However, the mechanisms underlying its anticancer effects remain largely unresolved. In this study, we investigated the chemoprotective effects of dietary Res in an azoxymethane (AOM) induced precancerous colorectal lesion model in male Wistar rats. The metabolic alterations in urine, sera, and colonic tissues of experimental rats perturbed by AOM intervention as well as the Res treatment were measured by a gas chromatography time-of-flight mass spectrometry (GC-TOFMS) analysis. Significant alterations of metabolites were observed in AOM group in urine, sera, and colonic tissues, which were attenuated by Res treatment and concurrent with the histopathological improvement with significantly decreased aberrant crypt foci (ACF) incidence. Representative metabolites include depleted glucose, β-hydroxybutyrate (ketone body), hypoxanthine, and elevated branched chain amino acids (isoleucine and valine) and tryptophan in colonic tissue, as well as elevated serum aminooxyacetate and urinary 4-hydroxyphenylacetate and xanthurenate. These metabolic changes suggest that the preventive effect of Res is associated with attenuation of impaired glucose and lipid metabolism and elevated protein breakdown in colonic tissues from AOM-exposed rats. It also appears that Res induced significant metabolic alterations independent of the AOM-induced metabolic changes. The significantly altered metabolites identified in Res-AOM group relative to AOM group include arachidonate, linoleate, glutamate, docosahexaenoate, palmitelaidate, 2-aminobutyrate, pyroglutamate, and threonate, all of which are involved in inflammation and oxidation processes. This suggests that Res exerts the chemopreventive effects on ACF formation by anti-inflammatory and antioxidant mechanisms in addition to amelioration of AOM-induced mitochondrial disruption.

KW - AOM

KW - azoxymethane

KW - colorectal cancer

KW - gas chromatography time-of-flight mass spectrometry

KW - GC-TOFMS

KW - metabonomics

KW - resveratrol

UR - http://www.scopus.com/inward/record.url?scp=84861833964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861833964&partnerID=8YFLogxK

U2 - 10.1021/pr300284h

DO - 10.1021/pr300284h

M3 - Article

VL - 11

SP - 3436

EP - 3448

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 6

ER -